In conclusion, we have demonstrated that topical treatment of GCSE ameliorated the progression of experimental atopic dermatitis by reducing serum IgE and AD-associated pathogenic cytokines levels while increasing Foxp3 level. The gene discussed is IGHE; the disease is Alzheimer disease.